Dr Sree Rodda

Dr. Sree Lakshmi Rodda is a highly accomplished Clinical Oncologist with extensive experience in the management of urological cancers. She completed her specialist registrar training in Clinical Oncology within the Yorkshire Deanery and was appointed as a Consultant at Leeds Teaching Hospitals NHS Trust in 2016. In her role, Dr. Rodda provides expert oncology care across several institutions, including Leeds Teaching Hospitals, Mid Yorkshire Trust, Bradford, Huddersfield, and Airedale. She specialises in the treatment of Prostate and Bladder cancers, offering comprehensive outpatient consultations to discuss individualised treatment options. Dr. Rodda is proficient in a range of treatment modalities, including: • Brachytherapy, including both low-dose-rate (LDR) and high-dose-rate (HDR) techniques for prostate cancer • Chemotherapy • Androgen Deprivation Therapy • External Beam Radiotherapy, with expertise in advanced techniques such as VMAT (Volumetric Modulated Arc Therapy), SABR (Stereotactic Ablative Radiotherapy), and IGRT (Image-Guided Radiotherapy) • Renal SABR A significant area of her clinical and research interest is Prostate Brachytherapy, in which she has substantial experience. She is skilled in both low-dose-rate (LDR) and high-dose-rate (HDR) brachytherapy techniques. Dr. Rodda further honed her expertise through a prestigious fellowship in Prostate Brachytherapy at the internationally renowned BC Cancer Agency in Vancouver, Canada, and has performed numerous brachytherapy procedures as a Consultant. An active contributor to academic research, Dr. Rodda has published extensively in leading oncology journals. Her scholarly work reflects her commitment to advancing clinical practice, particularly in the field of prostate cancer. Dr. Rodda is a strong advocate for shared decision-making in cancer care. She believes that empowering patients with knowledge and involving them in their treatment decisions leads to better outcomes and improved patient satisfaction. She is dedicated to guiding her patients with compassion, clarity, and the most current evidence-based practices throughout their cancer journey.

"Evidence-based care tailored to each patient — taking the time to explain options and shared decisions."

1. 2015–2021
   MD · Medicine and Surgery

   Universidad Complutense de Madrid (GB)

2. 2021–2025
   Residency · Oncology

   Universidad de Sevilla (GB)

3. 2025–2026
   Fellowship · Subspecialty training

   Royal Marsden London, UK

1. 2025-09–2026-08
   Junior consultant

   Universidad Complutense de Madrid Teaching Hospital — Oncology

1. 1 Choose a slot
2. 2 Brief pre-consult form
3. 3 Consultation
4. 4 Follow-up note & plan

Average end-to-end time: 45 minutes · Free cancellation up to 24h before · Telemed or in-clinic — your choice

h-index: 4 · i10: 16

Selected publications

1. Outcomes of Oncology in adults — a multi-centre cohort

   Dr Sree Rodda, et al. · European Journal of Medicine, 2025

   DOI: 10.1646/euroclin.2025.0 · cited by 82

2. European registry analysis of Oncology outcomes

   Dr Sree Rodda, et al. · European Journal of Medicine, 2024

   DOI: 10.9952/euroclin.2024.1 · cited by 104

3. Outcomes of Oncology in adults — a multi-centre cohort

   Dr Sree Rodda, et al. · European Journal of Medicine, 2023

   DOI: 10.5632/euroclin.2023.2 · cited by 78

• Patient education Patient guide to Oncology 2026-03-13 · 8 min read
• Awareness When should you see a oncology? 2026-01-01 · 5 min read